Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Revenue: 2020-2025

Historic Revenue for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $260,000.

  • Insight Molecular Diagnostics' Revenue rose 126.09% to $260,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 520.87%. This contributed to the annual value of $1.9 million for FY2024, which is 25.15% up from last year.
  • As of Q3 2025, Insight Molecular Diagnostics' Revenue stood at $260,000, which was down 49.81% from $518,000 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Revenue registered a high of $3.6 million during Q4 2021, and its lowest value of $67,000 during Q3 2022.
  • Its 3-year average for Revenue is $572,727, with a median of $314,000 in 2023.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Revenue surged by 6,925.00% in 2021 and then tumbled by 93.19% in 2022.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Revenue stood at $3.6 million in 2021, then tumbled by 92.37% to $274,000 in 2022, then climbed by 14.60% to $314,000 in 2023, then surged by 373.25% to $1.5 million in 2024, then skyrocketed by 126.09% to $260,000 in 2025.
  • Its Revenue stands at $260,000 for Q3 2025, versus $518,000 for Q2 2025 and $2.1 million for Q1 2025.